SlideShare a Scribd company logo
1 of 57
PROF. M.C.BANSAL .
MBBS. MS . MICOG. FICOG.
FOUNDR PRINCIPAL & CONTROLLER;
JHALAWAR MEDICAL COLLEGE AND HOSPITAL, JHALWAR.
EX . PRINCIPAL & CONTROLLER;
MAHATMA GANDHI MEDICLA COLLEGE AND HOSPITAL,
SITAPURA , JAIPUR.
Hydrops Fetalis
 It is defined as generalized fetal edema or anasarca , which

can be detected by an Antenatal USG.
 It may be manifestation of a variety of underlying disorders.
 The condition is subdivided in to
(a) Immune hydrops .
( b) non immune hydrops.
immune variety is more common in developing countries as
Rh grouping is not an universal phenomenon .
Non immune variety is more common in the developed
countries; ratio being reported to be 9: 1 of non immune to
immune cases.
Rh –Ve persions ---India 5- 10 % 0f population –it is least in
Japan < 2% and 15 % in Europe and USA.
Development of Rh- D antibodies
When Rh +Ve RBCs enters the Rh-Ve mother’s blood circulation; they
stimulate the maternal immune response producing RBC antigen –
specific antibodies –isoimmunization (sensitization ) .
After few weeks , IgM antibodies ( Saline antibodies ) are produced.
IgM do not cross the placenta barrier Hence can not cause fetal
damage .
 On subsequent exposure of fetal Rh D antigen , her previously
primed B cells act swiftly to produce IgG ( albumin antibodies )
which can cross placenta ---and bounds to antigen of fetal RBCs
causing sequestration and destruction of fetal RBCs.
 Antibodies are formed in 16% of the mothers significantly after
6months of larger amount of fetomaternal bleeding and once
formed remain in circulation through the life. And each subsequent
pregnancy will have booster effect especially when fetus is Rh +Ve
fetus is in utero.
Schematic Diagram of antibody---Showing heavy , light chains and
antigen binding sites
Maternal

IgG

Fetal
Immune Hydrops
 The commonest cause of immune hydrops fetalis is

pregnancy in Rh negetive women with a Rh
positive fetus .
 Rh negetive mother who is already sensitized by
either by a previous pregnancy or blood
transfusion, is capable of producing
Immunogloblin G.
 These Immunoglobin G (IgG) antibodies cross the
placenta and destroy (haemolysed ) the Rh
positive RBCs of fetus.
 This phenomenon was reported by Levine in 1941.
Immune Hydrops Fetalis------ First pregnancy proceeds normally as Rh -ve mother is

usually not sensitized.
 Feto -placental maternal transfusion occurs at the time
of placental separation and the Rh +Ve fetal RBCs
sensitize t6he maternal immune system.
 Other procedures during pregnancy (even in first
pregnancy ) can sensitize the mother are feto- maternal
blood transfusion--- occuring in amnioscentesis ,
threatened abortion ,Ectopic pregnancy, MTP,D&E,
abruptio placenta, APH , External podalic version, IPV,
LSCS, MRP, Chorionic Villus Sampling , PIH , etc.
Immune Hydrops--- In subsequent pregnancy the fetal RBCs entering in






maternal circulation may be destroyed /or some of them
may have booster effect for maternal sensitization.
Maternal Immunoglobins G cross the placenta and
destroy fetal RBCs .
In mild cases, the fetus has haemolytic disease resulting
in anaemia with mild icterus.
In severe cases fetus develops hydrops fetalis.
If IgG titers are high the disease process may start even
in early period of gestation --- resulting in IUFD.
Degree of Risk of Developing isoimmunisation
according to period of gestation

Gestational period

%

After 1st trimester abortion

2%

After MTP ( mid trimester )

4-5%

At term after Delivery—ABO Rh
competability

ABO incompetable
ABO incompatibility confer
substantial protection against
developing Rh (D) issoimmunisation

16%----2% at the time of delivery , 7%
willdevelopanti D antibodie by the 6
months of delivery , another 7% get
sensibilized e.g. thy develop anti D
slowly and very low titre which
becomes detactable and measurable in
next prgnancy.
1.5 -2 %
Why all babies are not affected in
Rh –Ve mother
 Volume of fetomaternal trnsfusion may be too low to

sensitise.
 Immunological non responders ---pregnancy
induced suppression of immune system –30%.
 ABO Major group incompetability.
 Rh set up of the fetal blood may change the Rh –
antigenicity ( stimulus )
Feto- maternal haemorrhage During Antenatal
Period
 O.1mlof fetal RBCs are found in 5-15 % of women’s








circulation by 8 weeks of gestation.
75% cases it is always < 1ml .
1% show atleast 5ml fetal RBCs.
0.25% have more than 30ml of fetal RBCs hence only 1.5
% women get sensitised in Antenatal period .
It can be prevented by anti D therapy in antenatal period
---at 28 and 36 weeks of gestation and repating it after
delivery.
If any factor precipitating feto-maternal hemorrhage
need immediate anti d therapy in appropriate dose.
Prophylaxis---- Universal ABO Rh grouping of all girls / expactant

mother.
 Premarrital councellig regarding The Rh factor in both
life partners --- advising marriage of identical Rh factor.
 Rh Immunoglobulin (Rh-IgG) therapy within 24-48 hrs
to all Rh –Ve women after ectopic/MTP/ abortion/
delivery /amnioscentasis ,Version , APH bleeding and at
28th and 36th week of gestation in primigravida too..
 This therapy was introduced in1966 and its world wide
acceptance has remarkably reduced the incidence of
immune hydrops in developed countries , but it is still
common type of hydrops in developing world.
Hydrops fetalis
 Occasionally . Immune hydrops may be due to other

erythrocyte antigen apart from Rh D antigen.
 These include –major A.B.O. incopetability and
minor blood group antigens ---C D E, Kell , Jk, S, c ,
and Duffy.
 If issoimmunization occurs , then the titers of
antibodies are monitored at appropriate intervals
depending on the levels and rapidity with which they
are changing ( either every 2 or 4 weeks).
Rh Blood system
 Rh complex involves genetic expression of 3 separate alleles,







namely C,D,E and small d.
Genetic locus of Rh complex is situate on short arm of
chromosome 1.
D antigen is most potent and is responsible for almost all
cases of Rh incompatibility.
The potency of immune sensitivity of antigen is in the order
of D>d >C> E>e>c.
The commonest genotypes are Cede/ cede ,Cede / cede and
cede/CDE .
Capital D is dominant and express in clinical
sympatomatology—whenever present the person is called Rh
+Ve, while one having small dd is non effective hence taken
as Rh -Ve
Homozygous / Heterozygous Rh- Grouping.
 Homozygous Rh + Ve = DD ( D on both sets of

antigen--- mother and father both Have contributed
D &D.
 Homologous Rh –ve = dd eg. Each of both small d
parents have contributed set of small d( Maternal d
and paternal d)
 Heterozygous means---Rh +ve when Dd( one logus

has D and another logus has d) eg. D has come from
father / mother and d has come from Mother / father
– both parents have contributed different D and d.
Rh +Ve
Mother

Homogyous Rh
+Ve parents

Rh +Ve
Father

DD

All children Homogygous +Ve

D D

DD

DD

DD

DD

Both parents are Rh +ve ( DD) hence all 4 children will be Rh +Ve (DD)
Rh –Ve
mother

Rh +Ve Father
Homozygous

dd

Dd

DD

Dd

dD

dD

All 4 Children will be Rh +Ve ( heterogygous) as D is dominant while
d is recessive
Rh –ve Mother

Rh –Ve father

d d

d d

d d

d d

d d

all 4 children will be Rh -ve

d d
fetal Rh +ve RBCs enter in Rh-ve maternal circulation---Sensitise maternal
immune system ------Mother produce saline (IgM) & albumin (IgG ) antibodies
against fetal cells– IgG antibodies cross the placental blood barrier and reach to
fetal circulation and haemolyse the fetal cells resulting in HDFN
Antibody Formation ( Iso immunization of Rh -ve Mother ) Haemolysis of fetal
Rh+Ve RBCs
Characteristics of Rh -Immunoglobins
 Saline antibodies----

 It is IgG .

 It is IgM.

 Agglutinate with Rh +Ve

 Agglutinate Rh +ve RBCs

when suspended in saline.
 It appear first –before 24
weeks– and then decline
 Larger molecule.
 Can not cross placenta
hence can not cause
Haemolytic disease of fetus
and new born.








RBCs when suspended in
20% Albumin solution.
It appear later the saline
antibodies & continue to
increase as pregnancy
advances.
Small Molecule.
It crosses the placenta.
Causes haemolytic disease
of fetus and newborn .
Manifestation Of HDFN ( Erythroblastosis Fetalis

Depending upon the degree of fetal RBCs haemolysis ---It may
be -
1. Hydrops Fetalis ----Fetus is severely affected .
.
2. Icterus gravidorum neonatorum -----Relatively less
affected.
3.Congenital Anaemia ---of the newborn ; mildly affected .
Baby develops anaemia ; jaundice is not so evident or mild
, prognosis is good
Hydrops Fetalis
Severe form of Rh – HDFN.
2. Sever anaemia , generalised edema , ascites, and hydrothorax.
3. High cardiac output.
4. Liver damage due to fetal anoxaemia and acidosis.
5. Liver become the site of hemopoesis to compensate anemia due to
haemolysis.
6. Liver fails to produce proteins from aminoacids --hypoproteinaemia ; responsible for generalised edema.
7. Enlargement of placenta due to hyperplasia to meet the demand of
o2 transfusion to fetus.
8. USG---scalp edema ,skin edema, pericardial, pleural effusion and
ascites.
9. X-ray—buddha position __hallo around scalp—scalp edema .Limbs
apart ---due to abdominal distension.
10. Outcome  usually IUFD , sometime live birth but immediate
newborn death.
1.
Icterus Gravis Neonatorum
Lesser form of haemolytic disease than hydrops fetalis .
Newborn develops jaundice with in 24 hours after birth .
In uterus, most of the unconjugated bilirubin is washed
away through the placenta and thus no development of
fetal jaundice in utero.
After delivery excess of bilirubin is not excreted due to
failure of a large amount of bilirubin load by the liver of
neonate.
When serum bilirubin level rise above 20mg % it crosses
the blood brain barrier to deposit in basal ganglia
resulting in kernicterus.
This baby needs exchange transfusion.
Investigations
Blood in vials are sent to lab –
(a) 3ml oxalate / EDTA blood-- for Hb% and peripheral
smear.---Haemolysed RBCs, ghost cells (Maternal cells )
(b) 2ml clotted blood in another vial ---for ABO Rh
grouping , direct coomb’s test and serum bilrubin level .
DIRECT COOMB’S TEST  it is test to know , is baby is
affected by Rh –haemolytic disease or not .
If direct coomb’s test is +ve . it means baby is affected
and special management is to be done acoording to
serum bilirubin level .
As mother is already sensitized there is no role of
prophylactic anti D therapy .
If direct coomb’s test is –ve ---newborn is not affected by
Rh –iso immunizationi
Investigations

(a)INDIRECT COOMB’S TEST  RBC’s of specific or
mixed antigen ( KNOWN) are mixed with serum of
patient and anti human antiglobulin is added .
If agglutination of RBC’s occur ; it means antibodies
against Rh factor are present in patient’s blood.
Antibodies present in patient’s serum get attached to
RBCs and agglutination occurs.
Titer 1: 16 means agglutination occurs up to 16 times
dilution of patients serum .
(b)DIRECT COOMB’S TEST  Anti human anti globulin
are added directly to the rocs of baby.
Agglutination means anti bodies are bound to the rocs
of baby.
Immune Hdrops Fetalis
3 D image of fetus with features of immune
hydrops
Rh –is0 immune –Hyderops ( aNasarca)
Non Immune Hydrops Fetalis( USG) Trisomy case
Immunoprophylaxis
Routine antenatal Rh anti therapy is recommended
to Rh negetive women married to Rh+ve partner.
300 ug ,im in deltoid muscle at 28 weeks and 36
weeks of gestation.
1 0 0 u g , i m i s g i v e n a f t e r a n y b l e e d i n g i n 1 st
trimester.
Higher dose to be given after any precipitating
factor or procedure likely to cause feto placental
hemorrhage.
300ug anti D is sufficient to neutralize 15 ml of
have fetal cell/ 30ml of whole blood.
Measurement of fetomaternal
Haemorrhage
KLEIHAUER- BETKE TEST - Based on acid elution
technique. Fetal and maternal rocs have different
response to KOH solution.
Maternal cells (adult Hb ) get eluded leaving behind only
cell membrane and hence appear as swollen round large
―GHOST CELLS‖ against normal fetal cells whose Hb
remain unaltered hence look as red refractile round
cells .
If in 50 low power fields of maternal peripheral blood
80 fetal RBC’s are found- it is estimated that 4ml of
fetomaternal hemorrhage has occurred.
For 1ml of fetal blood 10ug of Rh anti D is needed. Thus
300ug anti D will be sufficient for 30 ml of fetal blood
which has entered the maternal circulation.
Materna l Adult
Hb Get eluded with
Fetal Hb Is
resistant to KOH

Maternal Adult Hb
gets elude by KOH --RBCs –Swollen with
fluid
Rh –ve(dd) fetus rarely may be exposed
to maternal D antigen as result of
materno fetal haemorrhage and may
become sensitized in their intra uterine
life. When such girl at her adult age
has pregnancy with Rh +ve fetus , the
very first fetus may suffer from HDFN .
this mechanism of isoimmunisation is
called GRAND MOTHER THEORY .
Unique complication of
Hydrops Fetalis where mother
develops anasarca similar to
fetus & PIH.
In a previously sensitized / sensibilized
women the antibody titer may rise to
high level in subsequent pregnancy.
This may occur in d-negative fetus also.
Non –IMMUNE Hydrops Fetalis causes--• INFECTIONS- Parvovirus B 19, Cytomegalovirus, Toxoplasma, Syphilis,
Herpes, Rubella, Leptospirosis.
• MATERNAL CAUSE -> Diabetes Mellitus, PIH, Severe Anaemia ,
Hypopteinaemia .
• CHONDROPLASIAS  Thanatophoic dwarfism, Osteogenesis Inperfecta,
Achondrogenesis, Hypophosphatasia.
• TWIN PREGNANCY  Twin to Twin Transfusion, Acardia Twin .

• CONGENITAL TUMORS  CNS, Renal, Genital, GIT, Pulmonary Hepatic &
Placental tumors, Sacrococygeal Teratoma, Tuberus sclerosis and
Neuroblastoma.

• INBORN ERRORS OF METABOLISM --.>Mucopolyscharidosis, Gausher’s
disease, Gangliosidosis, Neuramindase deficiency, Fetal Red cell disease -Alpha thalassaemia, Sicle cell, Spherocytosis, Elliptocytosis, and Morquio’s
disease.
Non immune --Hyudrops fetalis with large nenigo Myelocele in neck Region
Hydrops fetalis
Hydrops fetalis

More Related Content

What's hot

PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)Mohammed Musa
 
Intrauterine fetal death
Intrauterine fetal death Intrauterine fetal death
Intrauterine fetal death Rajesh Gajbhiye
 
Abnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleAbnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleKemi Dele-Ijagbulu
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancyraj kumar
 
Rh isoimmunization
Rh isoimmunizationRh isoimmunization
Rh isoimmunizationimanswati
 
Deep transverse arrest
Deep transverse arrestDeep transverse arrest
Deep transverse arrestpriya saxena
 
Haemorrhagic disease of newborn
Haemorrhagic disease of newbornHaemorrhagic disease of newborn
Haemorrhagic disease of newbornRabi Dhakal
 
Meconium aspiration syndrome_
Meconium aspiration syndrome_Meconium aspiration syndrome_
Meconium aspiration syndrome_Amlendra Yadav
 
Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseasesikramdr01
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancyFahad Zakwan
 
The gynaecological examination ppt
The gynaecological examination pptThe gynaecological examination ppt
The gynaecological examination pptReina Ramesh
 
Complete perineal tear
Complete perineal tearComplete perineal tear
Complete perineal tearmagdy abdel
 

What's hot (20)

Liver disease in pregnancy
Liver disease in pregnancyLiver disease in pregnancy
Liver disease in pregnancy
 
PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)PELVIC INFLAMMATORY DISEASE (PID)
PELVIC INFLAMMATORY DISEASE (PID)
 
HELLP SYNDROME
HELLP SYNDROME HELLP SYNDROME
HELLP SYNDROME
 
adenomyosis
adenomyosisadenomyosis
adenomyosis
 
Intrauterine fetal death
Intrauterine fetal death Intrauterine fetal death
Intrauterine fetal death
 
Abnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi DeleAbnormal Uterine Bleeding by Dr Kemi Dele
Abnormal Uterine Bleeding by Dr Kemi Dele
 
Heart disease in pregnancy
Heart disease in pregnancyHeart disease in pregnancy
Heart disease in pregnancy
 
Rh isoimmunization
Rh isoimmunizationRh isoimmunization
Rh isoimmunization
 
Deep transverse arrest
Deep transverse arrestDeep transverse arrest
Deep transverse arrest
 
Haemorrhagic disease of newborn
Haemorrhagic disease of newbornHaemorrhagic disease of newborn
Haemorrhagic disease of newborn
 
Prom
PromProm
Prom
 
Meconium aspiration syndrome_
Meconium aspiration syndrome_Meconium aspiration syndrome_
Meconium aspiration syndrome_
 
Adenomyosis
AdenomyosisAdenomyosis
Adenomyosis
 
Molar pregnancy
Molar pregnancyMolar pregnancy
Molar pregnancy
 
Gestational trophoblastic diseases
Gestational trophoblastic diseasesGestational trophoblastic diseases
Gestational trophoblastic diseases
 
Multiple pregnancy
Multiple pregnancyMultiple pregnancy
Multiple pregnancy
 
The gynaecological examination ppt
The gynaecological examination pptThe gynaecological examination ppt
The gynaecological examination ppt
 
Complete perineal tear
Complete perineal tearComplete perineal tear
Complete perineal tear
 
Abruptio placentae
Abruptio placentae Abruptio placentae
Abruptio placentae
 
Ectopic pregnancy
Ectopic pregnancyEctopic pregnancy
Ectopic pregnancy
 

Similar to Hydrops fetalis

Topic 19: Alloimmunization in Pregnancy.pdf
Topic 19: Alloimmunization in Pregnancy.pdfTopic 19: Alloimmunization in Pregnancy.pdf
Topic 19: Alloimmunization in Pregnancy.pdflaylarox27
 
Red cell alloimmunization (JUNE 2021)
Red cell alloimmunization (JUNE 2021)Red cell alloimmunization (JUNE 2021)
Red cell alloimmunization (JUNE 2021)OBGYN Notes
 
Rh incompatibility
Rh incompatibilityRh incompatibility
Rh incompatibilitysharaniya m
 
RHESUS ISOIMMUNIZATION.pptx
RHESUS ISOIMMUNIZATION.pptxRHESUS ISOIMMUNIZATION.pptx
RHESUS ISOIMMUNIZATION.pptxSARMADALITUNIO
 
ISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCYISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCYLipi Mondal
 
RH ISO IMMUNISATION.pptx 2.pptx
RH ISO IMMUNISATION.pptx 2.pptxRH ISO IMMUNISATION.pptx 2.pptx
RH ISO IMMUNISATION.pptx 2.pptxchitragupta55
 
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023Dr. Elioba J. Raimon
 
Haemolytic disease of new born
 Haemolytic disease of new born Haemolytic disease of new born
Haemolytic disease of new bornAzraKhan37
 
Rh negative pregnancy
Rh negative pregnancyRh negative pregnancy
Rh negative pregnancyobgymgmcri
 
hemolyticdisease-190822150040 5.pdf
hemolyticdisease-190822150040 5.pdfhemolyticdisease-190822150040 5.pdf
hemolyticdisease-190822150040 5.pdfConstance39
 
11. Rh isoimmunization.ppt
11. Rh isoimmunization.ppt11. Rh isoimmunization.ppt
11. Rh isoimmunization.pptFenembarMekonnen
 
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdfDrPNatarajan2
 
Hemolytic disease of the newborn. Diagnosis & Treatment
Hemolytic disease of the newborn. Diagnosis & TreatmentHemolytic disease of the newborn. Diagnosis & Treatment
Hemolytic disease of the newborn. Diagnosis & TreatmentEneutron
 

Similar to Hydrops fetalis (20)

Hydrops 2014 gphc
Hydrops 2014 gphcHydrops 2014 gphc
Hydrops 2014 gphc
 
Topic 19: Alloimmunization in Pregnancy.pdf
Topic 19: Alloimmunization in Pregnancy.pdfTopic 19: Alloimmunization in Pregnancy.pdf
Topic 19: Alloimmunization in Pregnancy.pdf
 
Red cell alloimmunization (JUNE 2021)
Red cell alloimmunization (JUNE 2021)Red cell alloimmunization (JUNE 2021)
Red cell alloimmunization (JUNE 2021)
 
Rh incompatibility
Rh incompatibilityRh incompatibility
Rh incompatibility
 
Iso immunization
Iso immunizationIso immunization
Iso immunization
 
Rh incompatility
Rh incompatilityRh incompatility
Rh incompatility
 
Rh incompatibility
Rh incompatibilityRh incompatibility
Rh incompatibility
 
Blood groups ii l
Blood groups ii  lBlood groups ii  l
Blood groups ii l
 
RHESUS ISOIMMUNIZATION.pptx
RHESUS ISOIMMUNIZATION.pptxRHESUS ISOIMMUNIZATION.pptx
RHESUS ISOIMMUNIZATION.pptx
 
ISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCYISO IMMUNIZATION IN PREGNANCY
ISO IMMUNIZATION IN PREGNANCY
 
RH ISO IMMUNISATION.pptx 2.pptx
RH ISO IMMUNISATION.pptx 2.pptxRH ISO IMMUNISATION.pptx 2.pptx
RH ISO IMMUNISATION.pptx 2.pptx
 
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023
ALLOIMMUNIZATION IN PREGNANCY BY DR. ELIOBA J. RAIMON 2023
 
Haemolytic disease of new born
 Haemolytic disease of new born Haemolytic disease of new born
Haemolytic disease of new born
 
Rh alloimmunization
Rh alloimmunizationRh alloimmunization
Rh alloimmunization
 
Rh negative pregnancy
Rh negative pregnancyRh negative pregnancy
Rh negative pregnancy
 
Hemolytic disease
Hemolytic diseaseHemolytic disease
Hemolytic disease
 
hemolyticdisease-190822150040 5.pdf
hemolyticdisease-190822150040 5.pdfhemolyticdisease-190822150040 5.pdf
hemolyticdisease-190822150040 5.pdf
 
11. Rh isoimmunization.ppt
11. Rh isoimmunization.ppt11. Rh isoimmunization.ppt
11. Rh isoimmunization.ppt
 
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf
45. NB NEONATAL HYPERBILIRUBINEMIA.ppt.pdf
 
Hemolytic disease of the newborn. Diagnosis & Treatment
Hemolytic disease of the newborn. Diagnosis & TreatmentHemolytic disease of the newborn. Diagnosis & Treatment
Hemolytic disease of the newborn. Diagnosis & Treatment
 

More from drmcbansal

Contracted pelvis
Contracted pelvisContracted pelvis
Contracted pelvisdrmcbansal
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
Mullerian anomalies
Mullerian anomaliesMullerian anomalies
Mullerian anomaliesdrmcbansal
 
PREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONSPREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONSdrmcbansal
 
Assisted reproductive techniques
Assisted reproductive techniquesAssisted reproductive techniques
Assisted reproductive techniquesdrmcbansal
 
Bio activity of preterm labour
Bio activity of preterm labourBio activity of preterm labour
Bio activity of preterm labourdrmcbansal
 
Usg in third trimester
Usg in third trimesterUsg in third trimester
Usg in third trimesterdrmcbansal
 
Assisted reproductive techniques
Assisted reproductive techniquesAssisted reproductive techniques
Assisted reproductive techniquesdrmcbansal
 
Sexuality and sexual dysfunction
Sexuality and sexual dysfunctionSexuality and sexual dysfunction
Sexuality and sexual dysfunctiondrmcbansal
 
Flow charts for gynaecological conditions
Flow charts  for gynaecological conditionsFlow charts  for gynaecological conditions
Flow charts for gynaecological conditionsdrmcbansal
 
Reproductive Hormones
Reproductive HormonesReproductive Hormones
Reproductive Hormonesdrmcbansal
 
Organizing an obstetrical critical care unit
Organizing an obstetrical critical care unit Organizing an obstetrical critical care unit
Organizing an obstetrical critical care unit drmcbansal
 
Endocrinology --- control of parturition
Endocrinology --- control of parturitionEndocrinology --- control of parturition
Endocrinology --- control of parturitiondrmcbansal
 
Imaging in obstetrics & gynaecology
Imaging in obstetrics & gynaecologyImaging in obstetrics & gynaecology
Imaging in obstetrics & gynaecologydrmcbansal
 
Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2drmcbansal
 
Mri in ob gy practice
Mri in ob  gy practiceMri in ob  gy practice
Mri in ob gy practicedrmcbansal
 
Sexuality and sexual dysfunction
Sexuality and sexual dysfunctionSexuality and sexual dysfunction
Sexuality and sexual dysfunctiondrmcbansal
 

More from drmcbansal (20)

Contracted pelvis
Contracted pelvisContracted pelvis
Contracted pelvis
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
Mullerian anomalies
Mullerian anomaliesMullerian anomalies
Mullerian anomalies
 
PREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONSPREGNANCY WITH CONVULSIONS
PREGNANCY WITH CONVULSIONS
 
Assisted reproductive techniques
Assisted reproductive techniquesAssisted reproductive techniques
Assisted reproductive techniques
 
Bio activity of preterm labour
Bio activity of preterm labourBio activity of preterm labour
Bio activity of preterm labour
 
Usg in third trimester
Usg in third trimesterUsg in third trimester
Usg in third trimester
 
Wound healing
Wound healingWound healing
Wound healing
 
Assisted reproductive techniques
Assisted reproductive techniquesAssisted reproductive techniques
Assisted reproductive techniques
 
Sexuality and sexual dysfunction
Sexuality and sexual dysfunctionSexuality and sexual dysfunction
Sexuality and sexual dysfunction
 
Flow charts for gynaecological conditions
Flow charts  for gynaecological conditionsFlow charts  for gynaecological conditions
Flow charts for gynaecological conditions
 
Reproductive Hormones
Reproductive HormonesReproductive Hormones
Reproductive Hormones
 
Organizing an obstetrical critical care unit
Organizing an obstetrical critical care unit Organizing an obstetrical critical care unit
Organizing an obstetrical critical care unit
 
Endocrinology --- control of parturition
Endocrinology --- control of parturitionEndocrinology --- control of parturition
Endocrinology --- control of parturition
 
Imaging in obstetrics & gynaecology
Imaging in obstetrics & gynaecologyImaging in obstetrics & gynaecology
Imaging in obstetrics & gynaecology
 
STD's
STD'sSTD's
STD's
 
Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2Imaging in obstetrics & gynaecology part 2
Imaging in obstetrics & gynaecology part 2
 
Mri in ob gy practice
Mri in ob  gy practiceMri in ob  gy practice
Mri in ob gy practice
 
Lasers
LasersLasers
Lasers
 
Sexuality and sexual dysfunction
Sexuality and sexual dysfunctionSexuality and sexual dysfunction
Sexuality and sexual dysfunction
 

Recently uploaded

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptxMaritesTamaniVerdade
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxEsquimalt MFRC
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxJisc
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfDr Vijay Vishwakarma
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfNirmal Dwivedi
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfPoh-Sun Goh
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 

Recently uploaded (20)

Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Wellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptxWellbeing inclusion and digital dystopias.pptx
Wellbeing inclusion and digital dystopias.pptx
 
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdfUnit 3 Emotional Intelligence and Spiritual Intelligence.pdf
Unit 3 Emotional Intelligence and Spiritual Intelligence.pdf
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 

Hydrops fetalis

  • 1. PROF. M.C.BANSAL . MBBS. MS . MICOG. FICOG. FOUNDR PRINCIPAL & CONTROLLER; JHALAWAR MEDICAL COLLEGE AND HOSPITAL, JHALWAR. EX . PRINCIPAL & CONTROLLER; MAHATMA GANDHI MEDICLA COLLEGE AND HOSPITAL, SITAPURA , JAIPUR.
  • 2. Hydrops Fetalis  It is defined as generalized fetal edema or anasarca , which can be detected by an Antenatal USG.  It may be manifestation of a variety of underlying disorders.  The condition is subdivided in to (a) Immune hydrops . ( b) non immune hydrops. immune variety is more common in developing countries as Rh grouping is not an universal phenomenon . Non immune variety is more common in the developed countries; ratio being reported to be 9: 1 of non immune to immune cases. Rh –Ve persions ---India 5- 10 % 0f population –it is least in Japan < 2% and 15 % in Europe and USA.
  • 3. Development of Rh- D antibodies When Rh +Ve RBCs enters the Rh-Ve mother’s blood circulation; they stimulate the maternal immune response producing RBC antigen – specific antibodies –isoimmunization (sensitization ) . After few weeks , IgM antibodies ( Saline antibodies ) are produced. IgM do not cross the placenta barrier Hence can not cause fetal damage .  On subsequent exposure of fetal Rh D antigen , her previously primed B cells act swiftly to produce IgG ( albumin antibodies ) which can cross placenta ---and bounds to antigen of fetal RBCs causing sequestration and destruction of fetal RBCs.  Antibodies are formed in 16% of the mothers significantly after 6months of larger amount of fetomaternal bleeding and once formed remain in circulation through the life. And each subsequent pregnancy will have booster effect especially when fetus is Rh +Ve fetus is in utero.
  • 4. Schematic Diagram of antibody---Showing heavy , light chains and antigen binding sites
  • 5.
  • 7.
  • 8. Immune Hydrops  The commonest cause of immune hydrops fetalis is pregnancy in Rh negetive women with a Rh positive fetus .  Rh negetive mother who is already sensitized by either by a previous pregnancy or blood transfusion, is capable of producing Immunogloblin G.  These Immunoglobin G (IgG) antibodies cross the placenta and destroy (haemolysed ) the Rh positive RBCs of fetus.  This phenomenon was reported by Levine in 1941.
  • 9. Immune Hydrops Fetalis------ First pregnancy proceeds normally as Rh -ve mother is usually not sensitized.  Feto -placental maternal transfusion occurs at the time of placental separation and the Rh +Ve fetal RBCs sensitize t6he maternal immune system.  Other procedures during pregnancy (even in first pregnancy ) can sensitize the mother are feto- maternal blood transfusion--- occuring in amnioscentesis , threatened abortion ,Ectopic pregnancy, MTP,D&E, abruptio placenta, APH , External podalic version, IPV, LSCS, MRP, Chorionic Villus Sampling , PIH , etc.
  • 10. Immune Hydrops--- In subsequent pregnancy the fetal RBCs entering in     maternal circulation may be destroyed /or some of them may have booster effect for maternal sensitization. Maternal Immunoglobins G cross the placenta and destroy fetal RBCs . In mild cases, the fetus has haemolytic disease resulting in anaemia with mild icterus. In severe cases fetus develops hydrops fetalis. If IgG titers are high the disease process may start even in early period of gestation --- resulting in IUFD.
  • 11. Degree of Risk of Developing isoimmunisation according to period of gestation Gestational period % After 1st trimester abortion 2% After MTP ( mid trimester ) 4-5% At term after Delivery—ABO Rh competability ABO incompetable ABO incompatibility confer substantial protection against developing Rh (D) issoimmunisation 16%----2% at the time of delivery , 7% willdevelopanti D antibodie by the 6 months of delivery , another 7% get sensibilized e.g. thy develop anti D slowly and very low titre which becomes detactable and measurable in next prgnancy. 1.5 -2 %
  • 12. Why all babies are not affected in Rh –Ve mother  Volume of fetomaternal trnsfusion may be too low to sensitise.  Immunological non responders ---pregnancy induced suppression of immune system –30%.  ABO Major group incompetability.  Rh set up of the fetal blood may change the Rh – antigenicity ( stimulus )
  • 13. Feto- maternal haemorrhage During Antenatal Period  O.1mlof fetal RBCs are found in 5-15 % of women’s      circulation by 8 weeks of gestation. 75% cases it is always < 1ml . 1% show atleast 5ml fetal RBCs. 0.25% have more than 30ml of fetal RBCs hence only 1.5 % women get sensitised in Antenatal period . It can be prevented by anti D therapy in antenatal period ---at 28 and 36 weeks of gestation and repating it after delivery. If any factor precipitating feto-maternal hemorrhage need immediate anti d therapy in appropriate dose.
  • 14. Prophylaxis---- Universal ABO Rh grouping of all girls / expactant mother.  Premarrital councellig regarding The Rh factor in both life partners --- advising marriage of identical Rh factor.  Rh Immunoglobulin (Rh-IgG) therapy within 24-48 hrs to all Rh –Ve women after ectopic/MTP/ abortion/ delivery /amnioscentasis ,Version , APH bleeding and at 28th and 36th week of gestation in primigravida too..  This therapy was introduced in1966 and its world wide acceptance has remarkably reduced the incidence of immune hydrops in developed countries , but it is still common type of hydrops in developing world.
  • 15. Hydrops fetalis  Occasionally . Immune hydrops may be due to other erythrocyte antigen apart from Rh D antigen.  These include –major A.B.O. incopetability and minor blood group antigens ---C D E, Kell , Jk, S, c , and Duffy.  If issoimmunization occurs , then the titers of antibodies are monitored at appropriate intervals depending on the levels and rapidity with which they are changing ( either every 2 or 4 weeks).
  • 16. Rh Blood system  Rh complex involves genetic expression of 3 separate alleles,      namely C,D,E and small d. Genetic locus of Rh complex is situate on short arm of chromosome 1. D antigen is most potent and is responsible for almost all cases of Rh incompatibility. The potency of immune sensitivity of antigen is in the order of D>d >C> E>e>c. The commonest genotypes are Cede/ cede ,Cede / cede and cede/CDE . Capital D is dominant and express in clinical sympatomatology—whenever present the person is called Rh +Ve, while one having small dd is non effective hence taken as Rh -Ve
  • 17. Homozygous / Heterozygous Rh- Grouping.  Homozygous Rh + Ve = DD ( D on both sets of antigen--- mother and father both Have contributed D &D.  Homologous Rh –ve = dd eg. Each of both small d parents have contributed set of small d( Maternal d and paternal d)  Heterozygous means---Rh +ve when Dd( one logus has D and another logus has d) eg. D has come from father / mother and d has come from Mother / father – both parents have contributed different D and d.
  • 18. Rh +Ve Mother Homogyous Rh +Ve parents Rh +Ve Father DD All children Homogygous +Ve D D DD DD DD DD Both parents are Rh +ve ( DD) hence all 4 children will be Rh +Ve (DD)
  • 19. Rh –Ve mother Rh +Ve Father Homozygous dd Dd DD Dd dD dD All 4 Children will be Rh +Ve ( heterogygous) as D is dominant while d is recessive
  • 20. Rh –ve Mother Rh –Ve father d d d d d d d d d d all 4 children will be Rh -ve d d
  • 21. fetal Rh +ve RBCs enter in Rh-ve maternal circulation---Sensitise maternal immune system ------Mother produce saline (IgM) & albumin (IgG ) antibodies against fetal cells– IgG antibodies cross the placental blood barrier and reach to fetal circulation and haemolyse the fetal cells resulting in HDFN
  • 22. Antibody Formation ( Iso immunization of Rh -ve Mother ) Haemolysis of fetal Rh+Ve RBCs
  • 23.
  • 24. Characteristics of Rh -Immunoglobins  Saline antibodies----  It is IgG .  It is IgM.  Agglutinate with Rh +Ve  Agglutinate Rh +ve RBCs when suspended in saline.  It appear first –before 24 weeks– and then decline  Larger molecule.  Can not cross placenta hence can not cause Haemolytic disease of fetus and new born.     RBCs when suspended in 20% Albumin solution. It appear later the saline antibodies & continue to increase as pregnancy advances. Small Molecule. It crosses the placenta. Causes haemolytic disease of fetus and newborn .
  • 25. Manifestation Of HDFN ( Erythroblastosis Fetalis Depending upon the degree of fetal RBCs haemolysis ---It may be - 1. Hydrops Fetalis ----Fetus is severely affected . . 2. Icterus gravidorum neonatorum -----Relatively less affected. 3.Congenital Anaemia ---of the newborn ; mildly affected . Baby develops anaemia ; jaundice is not so evident or mild , prognosis is good
  • 26. Hydrops Fetalis Severe form of Rh – HDFN. 2. Sever anaemia , generalised edema , ascites, and hydrothorax. 3. High cardiac output. 4. Liver damage due to fetal anoxaemia and acidosis. 5. Liver become the site of hemopoesis to compensate anemia due to haemolysis. 6. Liver fails to produce proteins from aminoacids --hypoproteinaemia ; responsible for generalised edema. 7. Enlargement of placenta due to hyperplasia to meet the demand of o2 transfusion to fetus. 8. USG---scalp edema ,skin edema, pericardial, pleural effusion and ascites. 9. X-ray—buddha position __hallo around scalp—scalp edema .Limbs apart ---due to abdominal distension. 10. Outcome  usually IUFD , sometime live birth but immediate newborn death. 1.
  • 27. Icterus Gravis Neonatorum Lesser form of haemolytic disease than hydrops fetalis . Newborn develops jaundice with in 24 hours after birth . In uterus, most of the unconjugated bilirubin is washed away through the placenta and thus no development of fetal jaundice in utero. After delivery excess of bilirubin is not excreted due to failure of a large amount of bilirubin load by the liver of neonate. When serum bilirubin level rise above 20mg % it crosses the blood brain barrier to deposit in basal ganglia resulting in kernicterus. This baby needs exchange transfusion.
  • 28. Investigations Blood in vials are sent to lab – (a) 3ml oxalate / EDTA blood-- for Hb% and peripheral smear.---Haemolysed RBCs, ghost cells (Maternal cells ) (b) 2ml clotted blood in another vial ---for ABO Rh grouping , direct coomb’s test and serum bilrubin level . DIRECT COOMB’S TEST  it is test to know , is baby is affected by Rh –haemolytic disease or not . If direct coomb’s test is +ve . it means baby is affected and special management is to be done acoording to serum bilirubin level . As mother is already sensitized there is no role of prophylactic anti D therapy . If direct coomb’s test is –ve ---newborn is not affected by Rh –iso immunizationi
  • 29. Investigations (a)INDIRECT COOMB’S TEST  RBC’s of specific or mixed antigen ( KNOWN) are mixed with serum of patient and anti human antiglobulin is added . If agglutination of RBC’s occur ; it means antibodies against Rh factor are present in patient’s blood. Antibodies present in patient’s serum get attached to RBCs and agglutination occurs. Titer 1: 16 means agglutination occurs up to 16 times dilution of patients serum . (b)DIRECT COOMB’S TEST  Anti human anti globulin are added directly to the rocs of baby. Agglutination means anti bodies are bound to the rocs of baby.
  • 31. 3 D image of fetus with features of immune hydrops
  • 32. Rh –is0 immune –Hyderops ( aNasarca)
  • 33.
  • 34. Non Immune Hydrops Fetalis( USG) Trisomy case
  • 35.
  • 36.
  • 37.
  • 38.
  • 39. Immunoprophylaxis Routine antenatal Rh anti therapy is recommended to Rh negetive women married to Rh+ve partner. 300 ug ,im in deltoid muscle at 28 weeks and 36 weeks of gestation. 1 0 0 u g , i m i s g i v e n a f t e r a n y b l e e d i n g i n 1 st trimester. Higher dose to be given after any precipitating factor or procedure likely to cause feto placental hemorrhage. 300ug anti D is sufficient to neutralize 15 ml of have fetal cell/ 30ml of whole blood.
  • 40. Measurement of fetomaternal Haemorrhage KLEIHAUER- BETKE TEST - Based on acid elution technique. Fetal and maternal rocs have different response to KOH solution. Maternal cells (adult Hb ) get eluded leaving behind only cell membrane and hence appear as swollen round large ―GHOST CELLS‖ against normal fetal cells whose Hb remain unaltered hence look as red refractile round cells . If in 50 low power fields of maternal peripheral blood 80 fetal RBC’s are found- it is estimated that 4ml of fetomaternal hemorrhage has occurred. For 1ml of fetal blood 10ug of Rh anti D is needed. Thus 300ug anti D will be sufficient for 30 ml of fetal blood which has entered the maternal circulation.
  • 41. Materna l Adult Hb Get eluded with
  • 42. Fetal Hb Is resistant to KOH Maternal Adult Hb gets elude by KOH --RBCs –Swollen with fluid
  • 43.
  • 44.
  • 45. Rh –ve(dd) fetus rarely may be exposed to maternal D antigen as result of materno fetal haemorrhage and may become sensitized in their intra uterine life. When such girl at her adult age has pregnancy with Rh +ve fetus , the very first fetus may suffer from HDFN . this mechanism of isoimmunisation is called GRAND MOTHER THEORY .
  • 46. Unique complication of Hydrops Fetalis where mother develops anasarca similar to fetus & PIH.
  • 47. In a previously sensitized / sensibilized women the antibody titer may rise to high level in subsequent pregnancy. This may occur in d-negative fetus also.
  • 48.
  • 49.
  • 50.
  • 51. Non –IMMUNE Hydrops Fetalis causes--• INFECTIONS- Parvovirus B 19, Cytomegalovirus, Toxoplasma, Syphilis, Herpes, Rubella, Leptospirosis. • MATERNAL CAUSE -> Diabetes Mellitus, PIH, Severe Anaemia , Hypopteinaemia . • CHONDROPLASIAS  Thanatophoic dwarfism, Osteogenesis Inperfecta, Achondrogenesis, Hypophosphatasia. • TWIN PREGNANCY  Twin to Twin Transfusion, Acardia Twin . • CONGENITAL TUMORS  CNS, Renal, Genital, GIT, Pulmonary Hepatic & Placental tumors, Sacrococygeal Teratoma, Tuberus sclerosis and Neuroblastoma. • INBORN ERRORS OF METABOLISM --.>Mucopolyscharidosis, Gausher’s disease, Gangliosidosis, Neuramindase deficiency, Fetal Red cell disease -Alpha thalassaemia, Sicle cell, Spherocytosis, Elliptocytosis, and Morquio’s disease.
  • 52.
  • 53.
  • 54.
  • 55. Non immune --Hyudrops fetalis with large nenigo Myelocele in neck Region